June 2025 in “Medical alphabet” The authors concluded that combining fractional lasers with topical therapy may be a promising and effective approach for treating androgenetic alopecia, offering high safety and tolerability.
February 2025 in “Aesthetic Plastic Surgery”
May 2024 in “Lasers in medical science” In this retrospective study, a combined therapy of ablative fractional Er: YAG laser and medication was more effective in treating male androgenetic alopecia than medication alone, without causing serious adverse effects, as evaluated over 24 weeks.
January 2023 in “The Egyptian Journal of Hospital Medicine” This study found that type A botulinum toxin treatment significantly increased hair thickness and reduced vellous hair count in patients with androgenetic alopecia, suggesting its potential as an effective therapy.
December 2023 in “Frontiers in oncology” The study found that patients over 70 with advanced ovarian cancer may have better overall and progression-free survival with weekly paclitaxel-carboplatin chemotherapy compared to a three-weekly regimen, despite increased blood-related toxicities.
1 citations
,
January 2024 in “Dermatologic Therapy” This study found that both methotrexate and azathioprine were equally effective and well-tolerated in improving symptoms of lichen planopilaris over six months, with no significant difference between the two treatments in terms of efficacy.
Topical finasteride effectively treats hair loss with fewer side effects than the oral form.
March 2026 in “Cosmoderma” This clinical study found that using a cream or lotion as an additional treatment alongside standard care for atopic dermatitis significantly reduced symptoms and improved skin moisturization and barrier function within 28 days compared to standard care alone in participants with mild-to-moderate eczema.
January 2026 in “Dermatology and Venerology” This study at the Dzerkalo Medical Center found that complex therapy for abscessing perifolliculitis of the scalp is more effective in reducing inflammation and follicle destruction compared to basic antibacterial therapy, which was associated with relapses during long-term follow-up.
September 2024 in “Journal of Clinical and Nursing Research” This study found that combining Chuzhi Shengfa Tablets with either ketoconazole shampoo or 5% minoxidil foam significantly improved hair density, hair diameter, and reduced scalp oil in men with androgenetic alopecia, without increasing adverse reactions.
In this study, researchers examined a document submitted by Jakeline Ortega related to Joandele Cristina da Silva Barcelos, but results or specific findings are not reported in the abstract.
January 2021 in “Lithuanian University of Health Sciences” September 2017 in “Eureka, Health Sciences/Eureka, Health Sciences.” In this study, chronotherapy was reported to be significantly more effective than traditional treatment for alopecia areata, resulting in hair regrowth in 53.3% of patients and improving various biochemical, immunological, and health markers.
January 2004 in “Zhongguo yiyuan yongyao pingjia yu fenxi” This study found that combining tamsulosin with finasteride was the most cost-effective treatment for mild to moderate BPH among the regimens tested.
November 2013 in “Journal of Mazandaran University of Medical Sciences” This study found that a topical solution of caffeine and minoxidil 2.5% was more effective in treating androgenetic alopecia than minoxidil 2.5% alone.
July 2016 in “Biometrics & Biostatistics International Journal” This article discusses the development of the Total View Guidelines for accurately reporting androgenic alopecia treatment effectiveness using uninterrupted video recordings and reports no new clinical results.
4 citations
,
November 2021 in “Journal of Cosmetic Dermatology” The researchers reported that QR678 Neo® combined with intralesional steroids significantly improved hair regrowth and patient satisfaction in treating alopecia areata compared to steroids alone.
4 citations
,
November 2001 in “PubMed” This study observed that 54% of men with male pattern hair loss showed hair growth improvement in the vertex region after 6 months of treatment with oral finasteride.
2 citations
,
June 2023 in “Current Nutrition & Food Science” This literature review highlights the therapeutic potential of the biflavonoid hinokiflavone, suggesting its biological importance against various cancers, inflammation, viral infections like COVID-19, and other conditions.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Topical finasteride effectively treats hair loss with fewer side effects than the oral form.
February 2026 in “Aesthetic Cosmetology and Medicine” In this case study, a 38-year-old woman with female androgenetic alopecia experienced improved hair density, reduced scalp oiliness, and enhanced hair structure after ten microneedle mesotherapy treatments combined with saw palmetto supplementation, with no adverse effects reported.
July 2025 in “International Journal of Pharmacy and Pharmaceutical Science” This review highlights the potential of herbal remedies as complementary options for breast cancer care, noting benefits like immune modulation and reduced chemotherapy side effects, in contrast to conventional treatments that often cause significant side effects and long-term health issues.
This study observed that both intradermotherapy with 5% minoxidil and topical minoxidil application resulted in perceived improvements in hair density and thickness among patients with androgenetic alopecia, with no significant difference between the two groups.
June 2024 in “The Open dermatology journal” In this study, researchers reported that an herbal extract with dihydroquercetin glucoside, epigallocatechin gallate glucoside, zinc, and glycine showed similar effectiveness and safety to minoxidil in treating androgenetic alopecia over 24 weeks, with no significant differences in hair growth outcomes between the groups.
October 2022 in “Our Dermatology Online” In this study, researchers compared the effectiveness of a tonic containing Capixyl, Procapil, and rosemary extract with 2% minoxidil in reducing hair loss and promoting hair growth in male participants over a 24-week period.
January 2019 in “Indian Journal of Dermatology, Venereology and Leprology”
68 citations
,
April 2002 in “Journal of Alternative and Complementary Medicine” This study suggests that botanical 5AR inhibitors like Serenoa repens and β-sitosterol may improve symptoms of androgenetic alopecia, with 60% of treated subjects showing improvement compared to placebo.
7 citations
,
January 2001 in “PubMed” This study found that vitamin B6 injections over several weeks improved hair condition and reduced hair loss in some women with diffuse alopecia, while calcium pantothenate had no clear positive effect.
June 2024 in “Archives of dermatological research” In this self-controlled comparative study of 16 women with Female Pattern Hair Loss, MMP® with Minoxidil showed a better response in the parietal-vertex regions in less advanced cases compared to standard Minoxidil treatment, though overall effectiveness was similar.
This protocol outlines a planned systematic review on the effectiveness and safety of non-conventional treatments for male androgenetic alopecia, reporting no new results.